{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-248059","form_type":"8-K","ticker":"VTRS","cik":"0001792044","company_name":"Viatris Inc","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.470915+00:00","generated_at":"2026-06-10T06:27:40.531007+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Viatris announces $6.94B in gross proceeds from remaining divestitures, achieving >12x multiple","bullets":["Aggregated gross proceeds up to $6.94B from biosimilars, OTC, API, Women's Health, and non-core markets.","OTC offer: gross consideration up to ~$2.17B (12.8x multiple); API/Women's Healthcare: up to ~$1.2B (9.9x).","Strategic decision to retain Viagra, Dymista, select OTC in certain markets; retained value ~$1.6B.","Divestitures expected to close by end of H1 2024; net proceeds to be used for debt paydown targeting 3.0x gross leverage.","Up to 12 facilities and >6,000 employees (15% workforce) may be conveyed, simplifying organization."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-248059","json":"https://secwatch.observer/filing/0001193125-23-248059.json","markdown":"https://secwatch.observer/filing/0001193125-23-248059.md","text":"https://secwatch.observer/filing/0001193125-23-248059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792044/000119312523248059/0001193125-23-248059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792044/000119312523248059/d470078d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:27:40.531007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}